GENinCode (LON:GENI) Shares Down 9.9% – Time to Sell?

GENinCode Plc (LON:GENIGet Free Report)’s share price dropped 9.9% during trading on Wednesday . The stock traded as low as GBX 3.10 ($0.04) and last traded at GBX 3.20 ($0.04). Approximately 915,767 shares traded hands during trading, an increase of 24% from the average daily volume of 736,967 shares. The stock had previously closed at GBX 3.55 ($0.05).

GENinCode Price Performance

The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.28. The company’s 50-day simple moving average is GBX 3.72 and its 200 day simple moving average is GBX 4.42. The stock has a market capitalization of £5.67 million, a price-to-earnings ratio of -0.93 and a beta of 0.66.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Further Reading

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.